NSD3 and head and neck squamous cell carcinoma: Unexpectedly, low expression of either NSD1, NSD2, or NSD3 predicted markedly reduced survival in HPV+ HNSCC over those patients with tumors expressing the NSD paralogs in the mid and high expression groups.